{"id":{"repo_id":"kings","oai_identifier":"oai:kclpure.kcl.ac.uk:studenttheses/74f5dffc-db59-478e-bf87-46b476092e31"},"canonical_url":"https://search.dev.ndltd.org/etd/kings/oai:kclpure.kcl.ac.uk:studenttheses/74f5dffc-db59-478e-bf87-46b476092e31","repository":{"repo_id":"kings","name":"King's College London","base_url":"https://kclpure.kcl.ac.uk/ws/oai"},"display":{"title":"Soluble urokinase plasminogen activator receptor in venous ulcers","abstract":"Compression therapy remains the only treatment option for venous ulcers with<br/>&lt;100% success. A better understanding of the mechanisms regulating venous<br/>ulcer healing might give rise to better treatments.<br/>Urokinsae plasminogen activator receptor (uPAR), a GPI anchored 3‐domain<br/>protein exists either attached to cell wall or in soluble forms (suPARI‐III, suPARI<br/>&amp; suPARII‐III fragments). Cleavage of uPAR results in a number of nonproteolytic<br/>functions that may be important in wound healing. Our aim was to<br/>determine whether suPAR and its fragments are present in the environment of<br/>venous ulcers and whether this receptor has a role in ulcer‐healing.<br/>Ulcer exudates and ulcer tissue biopsies were obtained from patients with<br/>confirmed venous leg ulcers. Venous ulcers that healed within 6months of<br/>compression therapy were classified as healers (H) while those that did not heal<br/>in this time were defined as non‐healers (NH). Time resolved fluorescence<br/>immunoassays (TR‐FIA) were validated for measurement of suPAR fragments.<br/>TR‐FIAs specifically detected their antigens in wound exudates, but not in tissue<br/>homogenates. All forms of suPAR fragments were detected within venous ulcer<br/>exudates. Levels of all 3 suPAR fragments were significantly higher in exudates<br/>obtained from H compared to NH. ELISA analysis of uPA and plasminogen<br/>acitvator inhibitor (PAI‐1) antigen revealed that levels were similar in ulcer<br/>exudates and tissue homogenates from H and NH.<br/>9<br/>Treatment of scratched keratinocyte cultures with exudates from H resulted in a<br/>greater coverage of the scratch compared with NH. Depletion of suPAR from<br/>exudates obtained from H resulted in cell death.<br/>Results from this study have shown the presence of suPAR fragments within<br/>venous ulcers with higher presence of suPAR fragments in H compared to NH.<br/>This data suggests a role of suPAR and its fragments in ulcer healing, although<br/>the precise mechanisms involved remain to be identified. Measurement of<br/>suPAR fragments may provide a prognostic indicator and a therapeutic target<br/>for the treatment of venous ulcers.","abstract_html":"Compression therapy remains the only treatment option for venous ulcers with&lt;br/&gt;&amp;lt;100% success. A better understanding of the mechanisms regulating venous&lt;br/&gt;ulcer healing might give rise to better treatments.&lt;br/&gt;Urokinsae plasminogen activator receptor (uPAR), a GPI anchored 3‐domain&lt;br/&gt;protein exists either attached to cell wall or in soluble forms (suPARI‐III, suPARI&lt;br/&gt;&amp;amp; suPARII‐III fragments). Cleavage of uPAR results in a number of nonproteolytic&lt;br/&gt;functions that may be important in wound healing. Our aim was to&lt;br/&gt;determine whether suPAR and its fragments are present in the environment of&lt;br/&gt;venous ulcers and whether this receptor has a role in ulcer‐healing.&lt;br/&gt;Ulcer exudates and ulcer tissue biopsies were obtained from patients with&lt;br/&gt;confirmed venous leg ulcers. Venous ulcers that healed within 6months of&lt;br/&gt;compression therapy were classified as healers (H) while those that did not heal&lt;br/&gt;in this time were defined as non‐healers (NH). Time resolved fluorescence&lt;br/&gt;immunoassays (TR‐FIA) were validated for measurement of suPAR fragments.&lt;br/&gt;TR‐FIAs specifically detected their antigens in wound exudates, but not in tissue&lt;br/&gt;homogenates. All forms of suPAR fragments were detected within venous ulcer&lt;br/&gt;exudates. Levels of all 3 suPAR fragments were significantly higher in exudates&lt;br/&gt;obtained from H compared to NH. ELISA analysis of uPA and plasminogen&lt;br/&gt;acitvator inhibitor (PAI‐1) antigen revealed that levels were similar in ulcer&lt;br/&gt;exudates and tissue homogenates from H and NH.&lt;br/&gt;9&lt;br/&gt;Treatment of scratched keratinocyte cultures with exudates from H resulted in a&lt;br/&gt;greater coverage of the scratch compared with NH. Depletion of suPAR from&lt;br/&gt;exudates obtained from H resulted in cell death.&lt;br/&gt;Results from this study have shown the presence of suPAR fragments within&lt;br/&gt;venous ulcers with higher presence of suPAR fragments in H compared to NH.&lt;br/&gt;This data suggests a role of suPAR and its fragments in ulcer healing, although&lt;br/&gt;the precise mechanisms involved remain to be identified. Measurement of&lt;br/&gt;suPAR fragments may provide a prognostic indicator and a therapeutic target&lt;br/&gt;for the treatment of venous ulcers.","abstract_has_math":false,"creators":["Ahmad, Anwar"],"institution":"King's College London","degree_name":"Doctor of Medicine by Research","degree_level":"Doctoral Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Burnand, Kevin Guiver","Smith, Alberto"],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-1-1","date_published":"2014-1-1","updated_at":"2026-07-24T02:44:31Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:kclpure.kcl.ac.uk:studenttheses/74f5dffc-db59-478e-bf87-46b476092e31"],"render_values":[{"text":"oai:kclpure.kcl.ac.uk:studenttheses/74f5dffc-db59-478e-bf87-46b476092e31","href":null,"code":true}]}]},"links":{"outbound_url":"https://kclpure.kcl.ac.uk/portal/en/studentTheses/74f5dffc-db59-478e-bf87-46b476092e31","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Burnand, Kevin Guiver","Smith, Alberto"]},{"key":"dc:creator","label":"Author","values":["Ahmad, Anwar"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014-1-1"]},{"key":"dc:date.issued","label":"Date","values":["2014-1-1"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Vascular Risk & Surgery"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["King's College London"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://kclpure.kcl.ac.uk/portal/en/studentTheses/74f5dffc-db59-478e-bf87-46b476092e31"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Doctoral Thesis"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Doctor of Medicine by Research"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:kclpure.kcl.ac.uk:studenttheses/74f5dffc-db59-478e-bf87-46b476092e31","https://kclpure.kcl.ac.uk/portal/en/studentTheses/74f5dffc-db59-478e-bf87-46b476092e31"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://kclpure.kcl.ac.uk/portal/files/12375460/Studentthesis-Anwar_Ahmad_2014.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Compression therapy remains the only treatment option for venous ulcers with<br/>&lt;100% success. A better understanding of the mechanisms regulating venous<br/>ulcer healing might give rise to better treatments.<br/>Urokinsae plasminogen activator receptor (uPAR), a GPI anchored 3‐domain<br/>protein exists either attached to cell wall or in soluble forms (suPARI‐III, suPARI<br/>&amp; suPARII‐III fragments). Cleavage of uPAR results in a number of nonproteolytic<br/>functions that may be important in wound healing. Our aim was to<br/>determine whether suPAR and its fragments are present in the environment of<br/>venous ulcers and whether this receptor has a role in ulcer‐healing.<br/>Ulcer exudates and ulcer tissue biopsies were obtained from patients with<br/>confirmed venous leg ulcers. Venous ulcers that healed within 6months of<br/>compression therapy were classified as healers (H) while those that did not heal<br/>in this time were defined as non‐healers (NH). Time resolved fluorescence<br/>immunoassays (TR‐FIA) were validated for measurement of suPAR fragments.<br/>TR‐FIAs specifically detected their antigens in wound exudates, but not in tissue<br/>homogenates. All forms of suPAR fragments were detected within venous ulcer<br/>exudates. Levels of all 3 suPAR fragments were significantly higher in exudates<br/>obtained from H compared to NH. ELISA analysis of uPA and plasminogen<br/>acitvator inhibitor (PAI‐1) antigen revealed that levels were similar in ulcer<br/>exudates and tissue homogenates from H and NH.<br/>9<br/>Treatment of scratched keratinocyte cultures with exudates from H resulted in a<br/>greater coverage of the scratch compared with NH. Depletion of suPAR from<br/>exudates obtained from H resulted in cell death.<br/>Results from this study have shown the presence of suPAR fragments within<br/>venous ulcers with higher presence of suPAR fragments in H compared to NH.<br/>This data suggests a role of suPAR and its fragments in ulcer healing, although<br/>the precise mechanisms involved remain to be identified. Measurement of<br/>suPAR fragments may provide a prognostic indicator and a therapeutic target<br/>for the treatment of venous ulcers."]},{"key":"dc:title","label":"Title","values":["Soluble urokinase plasminogen activator receptor in venous ulcers"]}]}],"canonical_facts":{"dc:contributor.advisor":["Burnand, Kevin Guiver","Smith, Alberto"],"dc:creator":["Ahmad, Anwar"],"dc:date":["2014-1-1"],"dc:date.issued":["2014-1-1"],"dc:description.abstract":["Compression therapy remains the only treatment option for venous ulcers with<br/>&lt;100% success. A better understanding of the mechanisms regulating venous<br/>ulcer healing might give rise to better treatments.<br/>Urokinsae plasminogen activator receptor (uPAR), a GPI anchored 3‐domain<br/>protein exists either attached to cell wall or in soluble forms (suPARI‐III, suPARI<br/>&amp; suPARII‐III fragments). Cleavage of uPAR results in a number of nonproteolytic<br/>functions that may be important in wound healing. Our aim was to<br/>determine whether suPAR and its fragments are present in the environment of<br/>venous ulcers and whether this receptor has a role in ulcer‐healing.<br/>Ulcer exudates and ulcer tissue biopsies were obtained from patients with<br/>confirmed venous leg ulcers. Venous ulcers that healed within 6months of<br/>compression therapy were classified as healers (H) while those that did not heal<br/>in this time were defined as non‐healers (NH). Time resolved fluorescence<br/>immunoassays (TR‐FIA) were validated for measurement of suPAR fragments.<br/>TR‐FIAs specifically detected their antigens in wound exudates, but not in tissue<br/>homogenates. All forms of suPAR fragments were detected within venous ulcer<br/>exudates. Levels of all 3 suPAR fragments were significantly higher in exudates<br/>obtained from H compared to NH. ELISA analysis of uPA and plasminogen<br/>acitvator inhibitor (PAI‐1) antigen revealed that levels were similar in ulcer<br/>exudates and tissue homogenates from H and NH.<br/>9<br/>Treatment of scratched keratinocyte cultures with exudates from H resulted in a<br/>greater coverage of the scratch compared with NH. Depletion of suPAR from<br/>exudates obtained from H resulted in cell death.<br/>Results from this study have shown the presence of suPAR fragments within<br/>venous ulcers with higher presence of suPAR fragments in H compared to NH.<br/>This data suggests a role of suPAR and its fragments in ulcer healing, although<br/>the precise mechanisms involved remain to be identified. Measurement of<br/>suPAR fragments may provide a prognostic indicator and a therapeutic target<br/>for the treatment of venous ulcers."],"dc:identifier":["oai:kclpure.kcl.ac.uk:studenttheses/74f5dffc-db59-478e-bf87-46b476092e31","https://kclpure.kcl.ac.uk/portal/en/studentTheses/74f5dffc-db59-478e-bf87-46b476092e31"],"dc:identifier.uri":["https://kclpure.kcl.ac.uk/portal/files/12375460/Studentthesis-Anwar_Ahmad_2014.pdf"],"dc:language":["eng"],"dc:publisher.department":["Vascular Risk & Surgery"],"dc:publisher.institution":["King's College London"],"dc:relation.isreferencedby":["https://kclpure.kcl.ac.uk/portal/en/studentTheses/74f5dffc-db59-478e-bf87-46b476092e31"],"dc:title":["Soluble urokinase plasminogen activator receptor in venous ulcers"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["Doctoral Thesis"],"dc:type.qualificationname":["Doctor of Medicine by Research"]},"updated_at":"2026-07-24T02:44:31Z"}